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I. Abstract  
Release of neurotransmitters to complete synaptic transmission is dependent upon the concerted 
action of the SNARE and SM (Sec1/Munc18) protein families. The SNARE complex, formed 
during synaptic vesicle fusion, is made up of syntaxin-1, SNAP-25, and synaptobrevin/VAMP. 
This process is catalyzed by the SM protein Munc18. We are interested in determining how the 
SNARE complex and VAMP2 are involved in the fusion of synaptic vesicles during the process 
of synaptic transmission, as little about these mechanisms is known. Previous studies suggested 
that without functional VAMP2 protein Munc-18 is no longer capable of stimulating the trans-
SNARE complex. Based upon this previous research two motifs within VAMP2 were targeted 
and a series of mutants designed, upon which functionality screens were performed. Our results 
show that nonfunctional VAMP2 mutants impair both endocytosis and exocytosis of 
neurotransmitters. Nonfunctional VAMP2 greatly reduces the frequency of spontaneous 
neurotransmitter release, and greatly reduces the amplitude of evoked neurotransmitter release.  
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
II. Introduction 
In order to function successfully, neurons must pass signals to specific target cells through synapses 
via vesicle fusion. Synaptic vesicle fusion is mediated by two different branches of proteins, the 
SNARE and Sec1/Munc18 (SM) families. SNARE-mediated synaptic transmission between neurons 
is required for memory, learning, and computational ability (Bear et al., 2007, pg 40). Located on 
the surface of the lipid membrane, the SNARE complex is a four-helical bundle made up of syntaxin-
1, SNAP-25, and synaptobrevin/VAMP (Zhou et al., 2013). All SNARES contain a conserved region 
of 60-70 amino acids within their cytosolic domain called the SNARE motif, which homo-dimerizes. 
V-SNARES on the vesicular membrane “zip together” with t-SNARES on the target membrane, 
becoming tightly bonded, and in the process cause the opposing membranes to fuse. 
  Thus, the neurotransmitters within the vesicle can be 
released into the target cell (Karp, 2010,  pg. 296-297). 
The importance of SNARE protein complex function is 
exemplified by the fact that it is the target of two bacterial 
toxins, botulism and tetanus. These toxins cleave neuronal 
SNAREs, blocking the release of neurotransmitters and 
causing paralysis (Karp, 2010, pg. 296). 
 Previously, it was determined that Sec1/Munc18 (SM) 
proteins were required for synaptic transmission, in particular 
Munc18-1 was determined to be essential to neurotransmitter 
release. Munc18-1 accelerates vesicle fusion by directly 
interacting with v- and t-SNARES of the trans-SNARE 
complex, increasing specificity and assisting zippering of the 
SNARE complex. The delivery of lipid cargo between 
membranes requires a fusion event which can be examined by 
using a Fluorescence Resonance Energy Transfer (FRET) 
based lipid mixing assay. Our group has used FRET to 
visualize fusion of liposomes in which neuronal SNARE 
proteins have been reconstituted at appropriate surface densities (Scott et al., 2002). In these studies, 
performed by Shailendra Rathore, a post-doctoral research scientist in Dr. Jingshi Shen’s lab, v-
Figure 1. Model for the General 
Mechanism of Fusion and SM 
Function.  Yellow-SM, Green-
Syntaxin, Blue-SNAP-25, Purple-
VAMP2 (From Shen et al., 2007) 
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liposomal fusion events were examined using the FRET pair NBD-PE (fluorophore) and Rho-PE 
(quencher). These lipid chromophores become diluted as the target and vesicular membranes fuse, 
and dequenching occurs as the chromophores are no longer in close proximity. This dequenching 
can be an indication of successful membrane fusion. Stimulation of Munc18 is greatly reduced when 
mutations in VAMP2 are present, but with no effect to the core SNARE catalytic function (Figure 
2). Two specific motifs of VAMP2 were found to be required for successful stimulation of vesicle 
fusion and lipid mixing – S61/E62 and S75/Q76 (Shen et al., 2007).  
 
VAMP2, a component of the SNARE complex, has been implicated in the process of storage vesicle 
fusion (Papini et al., 1995). VAMP2 complexes with syntaxin-1 and SNAP 25 from the presynaptic 
membrane, as well as a synaptic vesicle membrane protein (VAMP/synaptobrevin; Taubenblatt et 
al., 1999). In the absence of VAMP2, neurotransmitters are not transported across the synaptic 
membrane (Taubenblatt et al., 1999).When synaptic transmission does not proceed properly, it can 
result in a range of mental disorders. We are interested in determining how VAMP2 is involved in 
the fusion of synaptic vesicles in the process of synaptic transmission, as a protein within the SNARE 
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complex. To answer this question, we have performed a complementation screen to determine the 
functional domains of VAMP2 in vesicular fusion.  
III. Materials and Methods 
Primary Neuronal Cell Cultures 
Neuronal cultures were obtained from postnatal wild type mice on day 1 or 2 following birth. 
Neurons were plated on 18 mm coverslips in 12 well dishes, or 5 coverslips in a 60 mm Petri dish. 
Coverslips were first cleaned by soaking in concentrated nitric acid (70%); the coverslips were 
further sterilized by washing in MilliQ water several times and exposure to ultraviolet light for 30 
minutes, and finally coated with poly-L-lysine. The brain was removed, placed in the 
dissection/dissociation medium, and dissected. Hippocampal and cortex neurons were dissociated 
by trypsin (5 mg/mL for 5 min at 37°C). DNAase solution was added and incubated. The cell density 
was calculated and cells were plated at 1x10^5 cells per mL in plating medium. Cells were incubated 
in the cell culture incubator at 37 °C with 95% air and 5% CO2. Cells were maintained in Neurobasal 
medium supplemented with B-27, 2 mM glutamine, and pencillin/streptomycin. See protocol in 
(Beaudoin, 2012). All mice were handled according to the NIH guidelines for Animal Care & Use, 
and the procedures were approved by the Institutional Animal Care and Use Committee at the 
University of Colorado-Boulder.  
Plasmid Construction and production of lentiviruses 
From the University of Colorado Functional Genomics Facility a VAMP2 shRNA silencing 
lentiviral vector was obtained. This vector targets a sequence within the 3’UTR of the mouse 
VAMP2 gene (5’-CCGACCACAATCTGGTTCTTT-3’). The pLKO-puro lentivirus vector (Sigma-
Aldrich Co. LLC) along with three packaging plasmids (VSVG, pSPAX, and pAdvantage) were 
cotransfected into HEK293T cells at 0.5 ug, 5 ug, and 1 ug per 100 mm cell culture respectively, 
using the transfection reagent PEE25. Cell culture supernatants were collected every 24 hours 
following transfection for 3 days and used directly in infection of neurons or stored at -80°C. 
Neuronal cultures were infected DIV 6 by adding 20 uL of viral suspension per well, and examined 
using electrophysiology DIV 16-20.  
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Plasmid Sequence 
The vector TRC2- pLKO-puro lentivirus was 
used, which is 7,518 bp in length. In order to 
create the VAMP2 rescue the puroR gene (an 
antibiotic gene) within this vector was selectively 
removed using BamH1 and Kpn1 splicing factors, 
and was replaced with the mouse VAMP2 gene 
sequence. In this rescue the mouse VAMP2 gene 
which had been cloned in is driven by the hPGK 
promoter, allowing for the simultaneous 
expression of the shRNA VAMP2 and the 
VAMP2 mouse gene.  All mutant constructs were designed using site-directed mutagenesis, and 
verified using sequencing. The transgene was then delivered by the lentivirus. This particular vector 
allows for the production of stable lentiviral particles, as well as for transfection of the cell culture. 
The 3’UTR was used as the targeting region for the shRNA in order to conserve the coding region 
of VAMP2.  
 
 
 
Figure 4. Schematic of pLKO lentiviral Knockdown construct and Knockdown Rescue construct. In 
both of these constructs the cppt gene is replaced with a shRNA coding region, driven by the U6 
promoter. In the Knockdown Rescue construct the puroR gene is replaced with the WT VAMP2 
sequence and transcription is independently driven by the hPGK promoter. 
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There were two controls: 
TurboGFP Control 
The TurboGFP control (Sigma-Aldrich Co. LLC) is used as a positive control in 
transfection/infection. This pLKO construct contains a TurboGFP tag driven by the CMV promoter.  
Non-Mammalian shRNA Control 
The Non-target shRNA control (Sigma-Aldrich Co. LLC) is used as a negative control. It is a version 
of the pLKO construct containing an shRNA insert which does not align with any BLAST product. 
This control allows us to examine the potential effects of infecting cells with a shRNA on gene 
expression.  
There were four mutants of interest: 
VAMP2 WT 
        5          10         15         20        25         30         35          40          45          50          55         60         65          70          75        80        
SATAATAPPAAPAGEGGPPAPPPNLTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSAAKL 
 
VAMP2 L63A Mutant 
        5          10         15         20        25         30         35          40          45          50          55         60         65          70          75        80        
SATAATAPPAAPAGEGGPPAPPPNLTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSEADDRADALQAGASQFETSAAKL 
 
VAMP2 L60A Mutant 
        5          10         15         20        25         30         35          40          45          50          55         60         65          70          75        80        
SATAATAPPAAPAGEGGPPAPPPNLTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKASELDDRADALQAGASQFETSAAKL 
 
VAMP2 S61D/E62H Mutant  
        5          10         15         20        25         30         35          40          45          50          55         60         65          70          75        80        
SATAATAPPAAPAGEGGPPAPPPNLTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLDHLDDRADALQAGASQFETSAAKL 
 
VAMP2 S75E/Q76H Mutant 
        5          10         15         20        25         30         35          40          45          50          55         60         65          70          75        80        
SATAATAPPAAPAGEGGPPAPPPNLTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGAEHFETSAAKL 
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Titration Assay 
The titration assay was performed using the GFP control, which contained the viral construct with a 
GFP tag, but no targeting shRNA inserted. Following transfection into the HEK293T cells, these 
cells were examined under a fluorescent microscope at 1:1, 1:10, 1:100, 1:1000, 1:10000, and 
1:100000 dilutions in order to determine the titer of the virus. Titer was calculated using the 
following equation: {(# cells at starting time)(dilution factor)(percent infection)}/(vol virus solution 
expressed in mls). The titer of GFP virus is normally 1X10^8 IU/ml.   Once the titer is calculated 
we further concentrate the supernatant about 10X by ultracentrifuge at 25k rpm for 2hr. Neuronal 
cultures are plated at 1X10^5 cells per ml, the titer of the virus is used to calculate the volume of 
virus needed to infect 100% of cells at a ratio of one virus per cell, then increased 10 fold due to the 
difficulty infecting neuronal cultures. Titer must be calculated each time an infection is performed 
since it can be variable. If only 80% of the neuronal cell culture is infected a Western Blot will no 
longer be reliable.  
Western Blot 
Immunoblotting was used to examine the knockdown efficiency and gene expression within the 
rescue. Neuronal cells which had been previously infected were separated at DIV 16-20 on 8% SDS-
PAGE gels. These membranes were stained using monoclonal anti-VAMP2 antibodies, monoclonal 
anti-syntaxin anitbodies, or anti-Bip antibodies. VAMP2 was detected using the secondary antibody 
goat Fluor 488-conjugated (Life Technologies), Syntaxin was detected using the secondary antibody 
goat rhodamine-conjugated (Jackson ImmunoResearch).  Chemiluminescence was detected using 
enhanced chemiluminescence (ECL) after the membrane was exposed to photographic film. 
FM4-64 labeling and Live Imaging 
FM4-64 labeling of recycling vesicles in live neurons and live imaging was performed following the 
described protocol in (Beaudoin, 2012, pg. 1744). Cultured neurons were incubated in Tyrode’s 
solution, high KCL Tyrode’s solution containing 10mM FM4-64, and Tyrode’s solution containing 
Advasep-7. Cells were fixed using 10mM FM4-64X and 4% paraformaldehyde. These cells were 
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examined using a confocal imaging system, FM4-64 can be excited between 510-570 nm and 
emission collected at 560-750 nm.  
Electrophysiology Recordings  
Electrophysiology Recordings were performed in whole-cell patch-clamp mode using a Multiclamp 
700B amplifier (Molecular Devices) to examine synaptic currents. Evoked synaptic transmission 
was stimulated by concentric bipolar electrodes placed 100-150 µm from the neuron, which 
delivered one millisecond current injections. The resistance of pipettes varied between 3 and 5 
Ohms, after the whole cell was patched resistance was adjusted to between 8 and 10 Ohms. The 
frequency, duration, and magnitude of extracellular stimuli were controlled by an Isolated Pulse 
Stimulator (World Precision Instruments). The whole cell pipette solution contained 135 mM CsCl, 
10 mM HEPES-CsOH (pH 7.25), 0.5 mM EGTA, 2 mM MgCl2, 0.4 mM NaCl-GTP, and 4 mM 
NaCl-ATP.  The bath solution contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 0.8 MgCl2, 10 
mM HEPES-NaOH (pH 7.4), and 10 mM Glucose. IPSCs and EPSCs were isolated by adding either 
the GABAA receptor blocker picrotoxin (50 µM) or the glutamate receptor blockers CNQX (20 µM) 
and AP-5 (50 µM) (all from Sigma) to the bath solution. In order to block action potentials the 
spontaneous mEPSCs and mIPSCs were analyzed using tetrodotoxin (TTX). Electrophysiological 
data were analyzed using the pClamp 10 software (Molecular Devices), statistical analysis were 
performed using Student’s t-tests. VAMP2 rescue mutants were compared to WT control neurons.  
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IV. Results 
 In order to determine the effects of VAMP2 mutations on synaptic transmission, we expressed four 
different mutant VAMP2 constructs in VAMP2 knockdown neuronal cultures. First, VAMP2 was 
silenced in mouse neuronal cultures using lentiviral constructs containing shRNAs. To determine 
the proper concentration of lentivirus necessary to infect mouse neuronal cultures, a GFP Titration 
Assay was performed (Figure 3). The titration assay is necessary to accurately determine the titer of 
the virus as neuronal cell cultures are more difficult to infect and the titer can vary. A GFP control 
was used during transfection, containing a GFP tag but no shRNA silencing elements.  
As shown in Figure 3, the lentivirus concentrations are increased 10 fold, and the neurons are 
typically infected at an adjusted titer so that there is ~100% infection rate. The levels of transfection 
are comparable to that of the other constructs used in our experiments.  
 
 
11 
 
Knockdown efficiency of multiple VAMP2 knockdown constructs was determined by 
immunoblotting. The WT form of VAMP2 was compared to a GFP control construct, a shRNA 
control without any targeting shRNA, and three separate knockdowns. V1 contains a shRNA 
sequence within the 3’UTR, while V2 and V4 contain the shRNA targeting region within their 
coding regions. V1 is a more reliable knockdown to use because the shRNA targeting region has no 
effect on the construct’s coding region and is not predicted to cause interference. Incorporating the 
shRNA targeting region into the 3’UTR is also more efficient, if the shRNA targeting region is 
incorporated within the coding region of the protein it is necessary to perform a mutagenesis. The 
data illustrates that no VAMP2 protein is present in V1, V2, or V4 (Figure 4). Also no unexpected 
interference results from the addition of a GFP tag or the use of shRNA on gene expression. Syntaxin 
was detected in order to ensure synaptic formation was normal, and that the shRNA was specifically 
targeting VAMP2. Bip was used as an indication of ER stress, and acted as a loading control. 
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Once knockdown cell lines were obtained, we expressed the mutant constructs of interest to perform 
the complementation assay. The expression level of VAMP2 rescue mutants was examined using 
immunoblotting. VAMP2 knockdown with four different rescue constructs was compared to 
wildtype VAMP2 expressed at endogenous levels (CTR). A wild type rescue construct as well as 
four rescue mutant constructs, two with single point mutations (L63A and L60A) and two with 
double mutations (S61D/E62H and S75E/Q76H) expression levels were compared. The expression 
level of VAMP2 rescue mutants was examined via immunoblotting, and each cell line was 
determined to have similar VAMP2 protein levels as the WT control. (Figure 5).  Syntaxin was used 
to ensure synapse formation was normal, and that the shRNA was targeting specifically VAMP2. 
The effects of mutant VAMP2 expression on endocytosis during synaptic transmission were 
analyzed using FM4-64 dye. FM dyes are amphiphilic styryls which insert into one leaflet of the 
lipid bilayer through a lipophilic tail. During endocytosis the dye becomes entrapped within 
vesicles and fluoresces, allowing it to be used as a marker of synaptic transmission. 
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Following exposure to the FM dye the cells are washed and any remaining FM dye is present 
within vesicles which have budded off from the plasma membrane. In VAMP2 knockdown cells 
there is very little fluorescence, while the Rescue WT shows significant fluorescence. Cells 
expressing the L60A mutant protein show comparable levels of fluorescence to those of the 
Rescue WT, illustrating that this mutant’s mutation has little effect on the functionality of 
VAMP2. S61D/E62H and S75E/Q76H show partial fluorescence when compared to the Rescue 
WT, and therefore most likely have partially functional VAMP2 proteins. L63A, on the other 
hand, shows a very low level of fluorescence comparable to that of the VAMP2 knockdown V1. 
The L63A mutation is significant because it has completely ablated VAMP2 functionality, thus 
affecting the fusion process (Bolte et al., 2004). 
Next, we examined the effects of the L60A and L63A VAMP2 mutations on neurotransmitter 
release/exocytosis using electrophysiology recordings. The S61D/E62H and S75E/Q76H VAMP2 
mutants were not examined as they demonstrated only partial effects on synaptic endocytosis. I was 
Figure 6. Analysis of Synaptic Transmission using FM4-64. The effect of the knockdown and VAMP2 
rescue mutants on synaptic transmission can be detected using fluorescence levels.  
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able to assist Dr. Chong Shen, a post-doctoral research scientist within Jingshi Shen’s lab, in some 
aspects of this work.  
The spontaneous neurotransmitter release was examined by monitoring miniature excitatory 
postsynaptic currents (mEPSCs). The VAMP2 knockdown greatly diminished the frequency of 
spontaneous neurotransmitter release (Figure 7), and could only be successfully rescued by the 
VAMP2 WT. Both the L63A and L60A VAMP2 mutants were unable to restore the frequency of 
spontaneous neurotransmitter release back to a wildtype level.  There was no effect on the amplitude 
of these neurotransmitter releases. This indicates that these mutations are detrimental to VAMP2 
protein’s functionality in regulating exocytosis during neurotransmitter release. In order to ensure 
these mutations had a universal effect on the mechanism of transmission, miniature inhibitory 
postsynaptic currents (mIPSCs) were also examined (Figure 8). Similarly, the L63A and L60A 
mutants demonstrated greatly reduced frequency of neurotransmitter release with little effect on the 
amplitude. Since both the mEPSCs and mIPSCs were affected by the VAMP2 knockdown as well 
as the VAMP2 mutants, it appears that these mutations universally affect the mechanism of SNARE 
mediated synaptic transmission.  
 
 
 
Figure 7. Electrophysiological analysis of VAMP2 impact on spontaneous 
neurotransmitter release by monitoring miniature excitatory postsynaptic 
currents. Test of the rescue ability of VAMP2 mutants.  (From Chong Shen)  
 
 Figure 7. Electrophysiological analysis of VAMP2 impact on spontaneous 
neurotransmitter release by monitoring miniature excitatory postsynaptic 
currents. Test of the rescue ability of VAMP2 mutants.  (From Chong Shen) 
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We also investigated the effects of the VAMP2 mutations on evoked neurotransmitter release.  
Action potential-evoked neurotransmitter release in the cultured neurons was triggered using 
electrical stimulus, then currents were quantified (Figure 9). The amplitude of these evoked EPSCs 
was greatly reduced by the L63A and L60A mutants. Neither of these mutants was capable of 
rescuing the VAMP2 knockdown, which demonstrated a greatly reduced amplitude as compared to 
the wildtype. The wildtype VAMP2 was capable of rescuing the VAMP2 knockdown and 
successfully restored evoked neurotransmitter release. The evoked IPSCs were affected in a similar 
manner (Figure 10); the VAMP2 knockdown greatly reduced the amplitude of the evoked IPSCs 
and was only successfully rescued by the VAMP2 wildtype. Neither mutant was capable of rescuing 
the knockdown phenotype.  
 
 Figure 8. Electrophysiological analysis of VAMP2 impact on spontaneous 
neurotransmitter release by monitoring miniature inhibitory postsynaptic 
currents. Test of the rescue ability of VAMP2 mutants. (From Chong Shen) 
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These results indicate that the loss of functional VAMP2 protein inhibits endocytosis, as well as 
spontaneous and evoked neurotransmitter release.  
 
 
 
 
 
 
 
 
 
 
 Figure 9. Electrophysiological analysis of VAMP2 impact on evoked neurotransmitter release by 
monitoring excitatory postsynaptic currents. Test of the rescue ability of VAMP2 mutants. (From 
Chong Shen) 
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V. Discussion  
In order to function properly, neurons must transmit signals to target cells via vesicle fusion in the 
neuronal synapse. VAMP2 is a necessary component of the SNARE complex and is required for 
vesicle fusion to take place. The  previous identification of two essential motifs in the v-SNARE 
VAMP2 (S61/E62 and S75/Q76) that appear to be indispensable in the Munc18-1/trans-SNARE 
interaction lead to further examination of VAMP2 and its potential implications in neurotransmitter 
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release. Mutations within these two motifs disrupt the catalytic role of Munc18-1 in SNARE 
complex zippering, but do not impact the formation of the trans-SNARE complex (Shen et al., 2007).  
The purpose of this research was to examine what residues of the VAMP2 protein are involved in 
the fusion of synaptic vesicles during synaptic transmission. We were able to successfully design 
and test an effective series of knockdowns and rescue mutants to examine the effects of knockdown 
and mutant VAMP2 expression in mouse neuronal cultures on SNARE mediated synaptic 
transmission. Once the efficiency and level of expression was verified using immunoblotting the 
knockdown (V1), rescue WT, and four rescue mutants implications in endocytosis were examined 
using FM4-64 dye. Of the four mutants L63A demonstrated the most intriguing results, as it reduced 
synaptic endocytosis to similar levels as the VAMP2 knockdown. L60A appeared to have little effect 
on endocytosis, while the S61D/E62H and S75E/Q76H mutants only had partial inhibition of 
synaptic endocytosis. Our electrophysiological data also indicate that the VAMP2 L60 and L63 
residues are required for neurotransmitter release. 
Previous work in the field of vesicular fusion has shown that the SNARE complex is required for 
neuronal transmission in vivo. Recently a correlation between genetic variations in VAMP2 and 
Idiopathic Generalized Epilepsy (IGE) has been observed in humans. IGE is believed to be 
dependent on genetic variations which impair synaptic processes (Yilmaz et al., 2013). To determine 
the function of VAMP2 in vesicular fusion in mice, I am interested in creating a VAMP2 knockdown 
mouse model. This model could be created by injecting a VAMP2-secific CRISPR sequence into 
mouse embryos, and then analyzing the neurological phenotype in adult animals. Based upon this 
previous research I expect that VAMP2 knockdown mice will display a phenotype similar to IGE 
patients.  
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